Medications
Aubagio approved for multiple sclerosis
(HealthDay)—Aubagio (teriflunomide) has been approved by the U.S. Food and Drug Administration to treat adults with relapsing forms of multiple sclerosis (MS).
Sep 13, 2012
0
0
Multiple Sclerosis
Neuroscience
Enzyme in myelination process could lead to better understanding of neurological disorders
The removal of the enzyme Dnmt1 during oligodendrocyte progenitor cell (OPC) differentiation in the central nervous system resulted in inefficient myelin formation and neurological deterioration, including loss of control ...
Apr 14, 2016
0
35
Neuroscience
Cells from placentas safe for patients with multiple sclerosis
Patients with Multiple Sclerosis (MS) were able to safely tolerate treatment with cells cultured from human placental tissue, according to a study published today in the journal Multiple Sclerosis and Related Disorders. The ...
Sep 29, 2014
0
3
Neuroscience
New treatment method looks to still tremors
There is no cure for tremor. That means for patients who suffer from the ailment – characterized by involuntary muscle contractions and shaking – ordinary tasks become increasingly difficult. Buttoning shirts, cooking ...
Jun 21, 2013
0
0
Neuroscience
Ozanimod successful in clinical trials for multiple sclerosis
Celgene Corporation recently announced results from two phase 3 trials evaluating the efficacy and safety of the drug ozanimod. Ozanimod was invented by scientists at The Scripps Research Institute (TSRI). Ozanimod is a novel, ...
Nov 10, 2017
0
5
Alzheimer's disease & dementia
Accused of complicity in Alzheimer's, amyloid proteins may be getting a bad rap
Amyloids—clumps of misfolded proteins found in the brains of people with Alzheimer's disease and other neurodegenerative disorders—are the quintessential bad boys of neurobiology. They're thought to muck up the seamless ...
Apr 3, 2013
1
0
Pediatrics
Expert calls for calm as France hit by cancer vaccine scare
One of France's top medical experts appealed for calm Monday as a scare over a widely administered vaccine that prevents cervical cancer gathered momentum.
Nov 25, 2013
0
0
Other
Irish biotech firm Elan rejects new Royalty bid
Irish biotechnology company Elan rejected on Monday the latest takeover bid from US group Royalty Pharma worth about $7.9 billion (6.0 billion euros).
Jun 10, 2013
0
0
Neuroscience
From chick to bedside: Removing the Wnt barrier
Kick starting a process that might repair the damage done in cerebral palsy and multiple sclerosis could begin with disabling a driver that helps block regeneration, said Baylor College of Medicine researchers in a report ...
Mar 5, 2015
0
86
Neuroscience
New imaging research shows increased iron in the brain in earliest stages of MS
While it's been known for over a century that iron deposits in the brain play a role in the pathology of Multiple Sclerosis (MS), new imaging research from Western University (London, Canada) helps to answer the question ...
Oct 28, 2013
0
0
